Skip to main content

Cheifetz named Executive Director and Chief Medical Officer, Duke Children's

Friday, January 19, 2018
Ira Cheifetz

Ann M. Reed, MD, William Cleland Professor of Pediatrics, Chair of the Department of Pediatrics and Physician-in-Chief, Duke Children’s recently announced the expanded Chief Medical Officer role of Ira M. Cheifetz, MD, FCCM, FAARC, as Executive Director for Duke Children’s.

Creation of this expanded role provides Dr. Cheifetz the ability to work with Dr. Reed in the oversight for the care of pediatric patients across the health system. Dr. Cheifetz will collaborate closely with DUH/DUHS senior leadership and work with Dr. Reed as Chair of the Department of Pediatrics and Physician-in-Chief of Duke Children’s as she leads the Duke Children’s Care for Children Strategy. Dr. Cheifetz has served as Chief Medical Officer for Duke Children’s and as an Associate Chief Medical Officer for Duke Hospital since 2013, and he will continue in these roles. 

Dr. Cheifetz graduated with honors from Yale Medical School in 1989 and completed his residency in pediatrics at Duke in 1992. After serving as chief resident, he completed a fellowship in pediatric critical care medicine and then joined the Duke faculty in 1996. He rose from Associate in Pediatrics to chief of the Pediatric Division of Critical Care Medicine in 2001 and Professor of Pediatrics in 2008. He served as Interim Chair of the Department of Pediatrics from 2013-2014.

Dr. Cheifetz has been a prolific clinical investigator in the neonatal and pediatric respiratory failure arena with numerous peer-reviewed publications, invited editorials, and text chapters. He has developed a strong national and international reputation for his work on cutting-edge therapies, such as high frequency oscillatory ventilation for children with intractable respiratory failure. Notably, Dr. Cheifetz was one of the first pediatric intensivists to recognize the benefit of real-time graphic monitoring in the management of mechanically ventilated children, and he was one of the first pediatric intensivists to utilize high frequency ventilation in the management of intractable respiratory failure. He is highly regarded for his commitment to teaching medical students, residents and fellows and is a frequently invited speaker nationally and internationally. 

"Dr. Cheifetz is a proven leader who ranks among the best senior practitioners in his area of expertise, and I look forward to our continued association in his new position," said Dr. Reed. Please join me in congratulating Dr. Cheifetz and supporting him in his new role."